Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 June 2023 | Story Sanchay Kalicharan | Photo Supplied
Sanchay Kalicharan
Sanchay Kalicharan, ETDP SETA Intern at DiMTEC

The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.

Sanchay Kalicharan, ETDP SETA Intern at DiMTEC, shares his UFS journey:

Q: Year of graduation from the UFS:

A: I graduated from the UFS Bloemfontein Campus in 2022.

Q: Qualification obtained from the UFS:

A: I obtained my Postgraduate Diploma in Disaster Management through the Disaster Management Training and Education Centre for Africa (DiMTEC) at the UFS.

Q: Date of joining the UFS as a staff member:

A: In August 2022, I embarked on a new journey as a staff member at the UFS. From the outset, the UFS provided a nurturing and challenging environment that fostered both personal and professional growth. As an intern, I was immersed in a diverse range of tasks and responsibilities that contributed significantly to my understanding of my chosen field.

The experience has been highly rewarding, equipping me with valuable insights and practical skills, while offering an opportunity to make meaningful contributions to the university's community. The camaraderie and support of my colleagues made for a dynamic work culture that drove excellence and innovation. Overall, joining the UFS marked a significant step on my career path.

Q: Initial job title and current job title:

A: In August 2022, I embarked on an enriching journey with the UFS as a PYEI intern at DiMTEC. Over the course of six months, I was deeply immersed in a variety of tasks, honing my skills, and gaining valuable insights into disaster management.

As my initial internship drew to a close in January 2023, a new chapter began. I transitioned into the role of an ETDP SETA intern with DiMTEC. From February 2023 till now, I have been extending my understanding and practical knowledge of the field. Each day brings a new learning opportunity, reinforcing the theoretical concepts I have studied with real-world applications. These successive roles at the UFS have played an integral part in shaping my professional career.

Q: How did the UFS prepare you for the professional world?

A: The UFS prepared me for the professional world in numerous ways. The internships I undertook at DiMTEC provided me with a robust platform to acquire practical skills and insights that are highly valuable in the professional world.

During my time as a PYEI intern, I was exposed to various facets of disaster management. This hands-on experience, paired with guidance from seasoned professionals, allowed me to delve into the complexities of the field and build my competency. Transitioning into the role of an ETDP SETA intern, I was able to further develop my understanding and skills in the disaster management field. The UFS provided continuous opportunities for learning and development, reinforcing theoretical knowledge with practical, real-world experiences.

In addition to the technical skills, the UFS also fostered the growth of soft skills such as teamwork, communication, problem-solving, and leadership, which are paramount in the professional world. Through collaborations, projects, and day-to-day interactions, I learned how to work effectively with diverse individuals, navigate challenges, and lead initiatives. This holistic training at the UFS has equipped me with the tools and confidence to navigate the professional landscape.

Q: What are your thoughts on transitioning from a UFS alumnus to a staff member?

A: Transitioning from a UFS alumnus to a staff member has been an enriching and rewarding journey. As a student, the university provided an excellent foundation of academic knowledge and practical skills. As a staff member, I have had the opportunity to apply and extend this knowledge, further deepening my understanding of my chosen field.

This transition has offered a different perspective on the workings of the institution. While my focus as a student was primarily on learning and personal development, as a staff member I am now contributing to the university's operations and its mission. This has given me a greater appreciation for the efforts that go into running such an institution, and the responsibilities that come with my role.

Being a part of the UFS staff also gives me a unique opportunity to give back to the community that has given so much to me during my student years. It is a chance to contribute to the academic and personal growth of current and future students, just as my teachers and mentors did for me. Overall, the transition has been a fulfilling experience and I look forward to continuing to make a positive impact in my role at the UFS.

Q: Any additional comments about your experience?

A: Throughout my journey at the UFS, both as an alumnus and as a staff member, I have found the environment to be nurturing and inspiring. Each role has brought new challenges and opportunities that have fostered my personal and professional growth.

The transition from being a student to joining the staff was seamless, largely due to the supportive community and culture of the UFS. I have been fortunate to collaborate with and learn from a diverse and talented group of professionals who are deeply committed to their work and the university's mission.

One significant aspect of my experience has been the real-world impact of the work we do at DiMTEC. It is fulfilling to know that our efforts contribute to the broader goal of enhancing disaster management strategies and practices.

Lastly, I greatly appreciate the continuous learning opportunities provided by the UFS. Whether it is through formal training, learning from colleagues, or tackling challenging projects, there is always an opportunity to learn and grow. This commitment to continuous learning is something I value deeply, and it fuels my passion for my work at the UFS.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept